At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 600 enrolled
Drug / intervention
Propofol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Satisfaction With Propofol for Out Patient Colonoscopy: A Prospective, Randomized, Double-Blind Study
In Brief
A Phase 4 clinical trial evaluating Propofol and Fentanyl Plus Midazolam for Colon Cancer and 2 related conditions. Completed, enrolled 600 participants across 1 site.
Detailed Summary
The primary purpose of this study is to determine if patient satisfaction with propofol is better than with non-propofol anesthesia for outpatient colonoscopies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColon Cancer, IBS, Polyps
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
Primary CompletionMar 2016
Study CompletionAug 2016
First PostedOct 2016
TodayJul 2026
First PostedOct 18, 2016
Enrollment StartNov 1, 2013
Primary CompletionMar 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.7 years ago
Interventions
Propofoldrug
The intervention is to use propofol as anesthesia during a colonoscopy.
Fentanyl Plus Midazolamdrug
The control is to use standard of care anesthesia, fentanyl and midazolam, during a colonoscopy.